Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02802033 · ClinicalTrials.gov registry record
A Multicenter Prospective Registry for the Management of Degenerative Spine Disorders
A clinical trial of Degenerative Diseases, Spinal Cord, sponsored by AO Innovation Translation Center.
- Active
- Registry status
- 908
- Enrollment target
- 7
- Study locations
NCT02802033 is a study of Degenerative Diseases, Spinal Cord that is active but no longer recruiting, run by AO Innovation Translation Center. The registered enrollment target is 908 participants. The trial reports 7 study locations across 5 states.
The verdict
NCT02802033, a study of Degenerative Diseases, Spinal Cord, is active but no longer recruiting, sponsored by AO Innovation Translation Center.
- ACTIVE NOT RECRUITING
- Registry status
- 908 participants
- Enrollment target
- 7
- Study locations
Study Summary
Details regarding the degenerative spine disorders will be collected with a specific focus on the use of osteobiologics in treating degenerative conditions and their impact on fusion, as well as patient-reported outcomes for these conditions.
Conditions Studied
Study Locations (7)
New York
- Mount Sinai Hospital - New York
- New York Presbyterian - Columbia University Medical Center - New York
Other
- BG-Clinic Bergmannstrost - Halle
- Istituto Ortopedico Rizzoli - Bologna
California
- USC Spine Center, Keck Medical Center of USC - Los Angeles
Georgia
- Emory University School of Medicine - Atlanta
Maryland
- The Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 908 participants |
| Start Date | 2016-01 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02802033
The ClinicalTrials.gov registry entry for NCT02802033 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 908 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AO Innovation Translation Center, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Degenerative Diseases, Spinal Cord appearing as the primary indexed condition, and to 0 interventions.
NCT02802033 reports 7 study locations spanning 5 distinct geographic areas - top geographies include New York, Other, California.
Frequently Asked Questions
What is clinical trial NCT02802033 about?
NCT02802033 is a clinical study titled "A Multicenter Prospective Registry for the Management of Degenerative Spine Disorders". Details regarding the degenerative spine disorders will be collected with a specific focus on the use of osteobiologics in treating degenerative conditions and their impact on fusion, as well as patient-reported outcomes for these conditions.
What is the current status of trial NCT02802033?
This trial is currently active not recruiting. The enrollment target is 908 participants. The study started on 2016-01. Estimated completion is 2026-12.
What conditions does trial NCT02802033 study?
This clinical trial studies the following conditions: Degenerative Diseases, Spinal Cord.
Who is sponsoring clinical trial NCT02802033?
This trial is sponsored by AO Innovation Translation Center, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02802033 being conducted?
This trial has 7 study locations across California, Georgia, Maryland, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.